MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

22 Apr 2022 Evaluate
The sales for the March 2022 quarter moved down to Rs. 52.92 millions as compared to Rs. 61.45 millions during the year-ago period.The Net Profit of the company slipped to Rs. 1.48 millions from Rs. 3.56 millions, a decline of -58.43% on QoQ basis.Operating profit for the quarter ended March 2022 decreased to 4.55 millions as compared to 5.57 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 52.92 61.45 -13.88 254.12 119.91 111.93 254.12 119.91 111.93
Other Income 2.05 1.37 49.64 6.73 4.60 46.30 6.73 4.60 46.30
PBIDT 4.55 5.57 -18.31 19.68 9.83 100.20 19.68 9.83 100.20
Interest 1.06 0.56 89.29 4.64 0.88 427.27 4.64 0.88 427.27
PBDT 3.49 5.01 -30.34 15.04 8.95 68.04 15.04 8.95 68.04
Depreciation 1.56 0.15 940.00 5.62 0.62 806.45 5.62 0.62 806.45
PBT 1.93 4.86 -60.29 9.42 8.33 13.09 9.42 8.33 13.09
TAX 0.45 1.30 -65.38 2.36 2.19 7.76 2.36 2.19 7.76
Deferred Tax 0.45 -0.01 -4600.00 2.34 -0.03 -7900.00 2.34 -0.03 -7900.00
PAT 1.48 3.56 -58.43 7.06 6.14 14.98 7.06 6.14 14.98
Equity 83.16 38.20 117.70 83.16 38.20 117.70 83.16 38.20 117.70
PBIDTM(%) 8.60 9.06 -5.15 7.74 8.20 -5.53 7.74 8.20 -5.53
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..